19 Apr 2017 --- The Norwegian Research Council has awarded a grant to NattoPharma to fund a four-year project to document the effects of calcium metabolism in the body based on the presence or absence of vitamin K2, MK7. The project will utilize NattoPharma’s MenaQ7 vitamin K2 as MK-7 and the research part is to be conducted at the Maastricht University in the Netherlands in the Department of Biochemistry under the guidance of Dr. Leon Schurgers, Senior Scientist and Associate Professor of Biochemistry at Maastricht and CARIM, the Cardiovascular Research Institute of Maastricht.